C-reactive protein and cardiovascular risk: more fuel to the fire.
Boekholdt
S Matthijs
SM
Department of Cardiology, Academic Medical Center, 1100DD Amsterdam, Netherlands. S.M.Boekholdt@amc.uva.nl
Kastelein
John J P
JJ
D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000097:blood* / Q000209:etiology / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood; D002986:Clinical Trials as Topic; D003657:Decision Making; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D018570:Risk Assessment; D012307:Risk Factors
D015415:Biomarkers; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein